Alphatec Holdings Inc
General ticker "ATEC" information:
- Sector: Health Care
- Industry: Health Care Equipment & Supplies
- Capitalization: $1.4B
Alphatec Holdings Inc does not follow the US Stock Market performance with the rate: -26.0%.
Estimated limits based on current volatility of 3.0%: low 8.93$, high 9.48$
Factors to consider:
- US accounted for 93.1% of revenue in the fiscal year ended 2022-12-31
- Earnings for 9 months up through Q3 exceed our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2023-12-31 to 2025-12-30
- 2023-12-31 to 2024-12-30 estimated range: [9.49$, 19.93$]
- 2024-12-30 to 2025-12-30 estimated range: [9.26$, 19.63$]
Financial Metrics affecting the ATEC estimates:
- Negative: Non-GAAP EPS, $ of -1.55 <= 0.10
- Negative: Operating profit margin, % of -26.45 <= 1.03
- Negative: negative Net income
- Negative: Operating cash flow per share per price, % of -4.67 <= 2.35
- Positive: -3.48 < Investing cash flow per share, $ of -1.17
- Positive: Industry inventory ratio change (median), % of 0.19 <= 0.49
- Positive: Inventory ratio change, % of -0.02 <= 0
- Negative: Industry operating cash flow per share per price (median), % of -5.15 <= 3.85
Short-term ATEC quotes
Long-term ATEC plot with estimates
Financial data
| YTD | 2021-12-31 | 2022-12-31 | 2023-12-31 |
|---|---|---|---|
| Operating Revenue | $243.21MM | $350.87MM | $482.26MM |
| Operating Expenses | $371.27MM | $497.84MM | $655.66MM |
| Operating Income | $-128.06MM | $-146.97MM | $-173.40MM |
| Non-Operating Income | $-16.11MM | $-5.03MM | $-13.52MM |
| Interest Expense | $7.11MM | $5.50MM | $16.64MM |
| R&D Expense | $32.02MM | $44.03MM | $70.11MM |
| Income(Loss) | $-144.16MM | $-152.01MM | $-186.91MM |
| Taxes | $0.16MM | $0.14MM | $-0.28MM |
| Profit(Loss) | $-144.33MM | $-152.15MM | $-186.64MM |
| Stockholders Equity | $79.42MM | $-36.71MM | $101.72MM |
| Inventory | $91.70MM | $101.52MM | $136.84MM |
| Assets | $572.05MM | $513.38MM | $805.21MM |
| Operating Cash Flow | $-73.43MM | $-75.14MM | $-78.48MM |
| Capital expenditure | $68.54MM | $58.28MM | $86.97MM |
| Investing Cash Flow | $-157.76MM | $-58.28MM | $-141.97MM |
| Financing Cash Flow | $311.97MM | $31.23MM | $356.92MM |
| Earnings Per Share* | $-1.50 | $-1.47 | $-1.54 |
* EPS are Split Adjusted, recent splits may be reflected with a delay.